Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB
- 31 August 2004
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 82 (4) , 286-295
- https://doi.org/10.1016/j.ymgme.2004.06.004
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrowMolecular Genetics and Metabolism, 2003
- A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N‐acetyl‐α‐D‐glucosaminidase deficiency in Schipperke dogsJournal of Inherited Metabolic Disease, 2003
- Neurological Correction of Lysosomal Storage in a Mucopolysaccharidosis IIIB Mouse Model by Adeno-associated Virus-Mediated Gene DeliveryMolecular Therapy, 2002
- Molecular Basis of Mucopolysaccharidosis Type IIIB in Emu (Dromaius novaehollandiae): An Avian Model of Sanfilippo Syndrome Type B<Genomics, 2001
- Molecular Architecture of the Brain Microvasculature: Perspective on Blood-Brain TransportJournal of Molecular Neuroscience, 2001
- Short-Term Enzyme Replacement in the Murine Model of Sanfilippo Syndrome Type BMolecular Genetics and Metabolism, 2000
- Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding α-N-acetylglucosaminidaseProceedings of the National Academy of Sciences, 1999
- The human gene mutation databaseTrends in Genetics, 1997
- Neuropsychological outcomes of several storage diseases with and without bone marrow transplantationJournal of Inherited Metabolic Disease, 1995
- Allogeneic bone marrow transplantation for lysosomal storage diseasesThe Lancet, 1995